Interferon Alpha mRNA level and subtypes in lesion and non-lesion from discoid lupus erythematosus patients without systemic lupus erythematosus

1. Kuhn A, Bijl M. Pathogenesis of cutaneous lupus erythematosus. Lupus. 2008; 17:389-93.10.1177/0961203308090019Open DOISearch in Google Scholar

2. Goldman M. Cytokines in the pathophysiology of systemic lupus erythematosus. Autoimmunity. 1990; 8:173-9.10.3109/08916939008995736Open DOISearch in Google Scholar

3. Hirankarn N, Avihingsanon Y, Wongpiyabovorn J. Genetic susceptibility to SLE is associated with TNF-alpha gene polymorphism -863, but not -308 and -238, in Thai population. Int J Immunogenet. 2007; 34:425-30.10.1111/j.1744-313X.2007.00715.xOpen DOISearch in Google Scholar

4. Blomberg S, Eloranta ML, Cederblad B, Nordlin K, Alm GV, Ronnblom L. Presence of cutaneous interferon-alpha producing cells in patients with systemic lupus erythematosus. Lupus. 2001; 10: 484-90.10.1191/096120301678416042Open DOISearch in Google Scholar

5. Farkas L, Beiske K, Lund-Johansen F, Brandtzaeg P, Jahnsen FL. Plasmacytoid dendritic cells (natural interferon- alpha/beta-producing cells) accumulate in cutaneous lupus erythematosus lesions. Am J Pathol. 2001; 159:237-43.10.1016/S0002-9440(10)61689-6Search in Google Scholar

6. Toro JR, Finlay D, Dou X, Zheng SC, LeBoit PE, Connolly MK. Detection of type 1 cytokines in discoid lupus erythematosus. Arch Dermatol. 2000; 136:1497-501.10.1001/archderm.136.12.149711115160Search in Google Scholar

7. Meller S, Winterberg F, Gilliet M, Muller A, Lauceviciute I, Rieker J, et al. Ultraviolet radiationinduced injury, chemokines, and leukocyte recruitment: An amplification cycle triggering cutaneous lupus erythematosus. Arthritis Rheum. 2005; 52:1504-16.10.1002/art.2103415880822Open DOISearch in Google Scholar

8. Wenzel J, Worenkamper E, Freutel S, Henze S, Haller O, Bieber T, et al. Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosus. J Pathol. 2005; 205:435-42.10.1002/path.172115685590Search in Google Scholar

9. Diaz MO, Pomykala HM, Bohlander SK, Maltepe E, Malik K, Brownstein B, et al. Structure of the human type-I interferon gene cluster determined from a YAC clone contig. Genomics. 1994; 22:540-52.10.1006/geno.1994.14278001965Open DOISearch in Google Scholar

10. Antonelli G. Biological basis for a proper clinical application of alpha interferons. New Microbiol. 2008; 31:305-18.Search in Google Scholar

11. Baig E, Fish EN. Distinct signature type I interferon responses are determined by the infecting virus and the target cell. Antivir Ther. 2008; 13:409-22.10.1177/135965350801300306Search in Google Scholar

12. Szubin R, Chang WL, Greasby T, Beckett L, Baumgarth N. Rigid interferon-alpha subtype responses of human plasmacytoid dendritic cells. J Interferon Cytokine Res. 2008; 28:749-63.10.1089/jir.2008.0037295669118937549Search in Google Scholar

13. Foster GR, Masri SH, David R, Jones M, Datta A, Lombardi G, et al. IFN-alpha subtypes differentially affect human T cell motility. J Immunol. 2004; 173: 1663-70.10.4049/jimmunol.173.3.166315265895Search in Google Scholar

14. Hilkens CM, Schlaak JF, Kerr IM. Differential responses to IFN-alpha subtypes in human T cells and dendritic cells. J Immunol. 2003; 171:5255-63.10.4049/jimmunol.171.10.525514607926Search in Google Scholar

15. Castelruiz Y, Larrea E, Boya P, Civeira MP, Prieto J. Interferon alfa subtypes and levels of type I interferons in the liver and peripheral mononuclear cells in patients with chronic hepatitis C and controls. Hepatology. 1999; 29:1900-4.10.1002/hep.51029062510347136Open DOISearch in Google Scholar

16. Avihingsanon Y, Phumesin P, Benjachat T, Akkasilpa S, Kittikowit V, Praditpornsilpa K, et al. Measurement of urinary chemokine and growth factor messenger RNAs: a noninvasive monitoring in lupus nephritis. Kidney Int. 2006; 69:747-53.10.1038/sj.ki.500013216518330Open DOISearch in Google Scholar

17. Larrea E, Alberdi A, Castelruiz Y, Boya P, Civeira MP, Prieto J. Expression of interferon-alpha subtypes in peripheral mononuclear cells from patients with chronic hepatitis C: a role for interferon-alpha5. J Viral Hepat. 2001; 8:103-10.10.1046/j.1365-2893.2001.00273.x11264730Search in Google Scholar

18. Larrea E, Aldabe R, Riezu-Boj JI, Guitart A, Civeira MP, Prieto J, et al. IFN-alpha5 mediates stronger Tyk2- stat-dependent activation and higher expression of 2',5'-oligoadenylate synthetase than IFN-alpha2 in liver cells. J Interferon Cytokine Res. 2004; 24:497-503.10.1089/107999004168960115320963Search in Google Scholar

19. Palmer P, Tovey MG, Raschilas F, Brassart L, Meritet JF, Porcher R, et al. Type I interferon subtypes produced by human peripheral mononuclear cells from one normal donor stimulated by viral and nonviral inducing factors. Eur Cytokine Netw. 2007; 18: 108-14.Search in Google Scholar

20. James CM, Abdad MY, Mansfield JP, Jacobsen HK, Vind AR, Stumbles PA, et al. Differential activities of alpha/beta IFN subtypes against influenza virus in vivo and enhancement of specific immune responses in DNA vaccinated mice expressing haemagglutinin and nucleoprotein. Vaccine. 2007; 25:1856-67.10.1016/j.vaccine.2006.10.03817240000Open DOISearch in Google Scholar